We don’t have too many examples of Oz biotechs getting bought for top $$$
Our target market is large BPs in the US, Europe and Asia, and our IP is also for these regions. I'd presume our Australia location isn't of great significance when it comes to licensing and partnerships.
- Forums
- ASX - By Stock
- Ann: Race continues Board renewal - appoints new Chair
We don’t have too many examples of Oz biotechs getting bought...
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.89 |
Change
0.120(6.80%) |
Mkt cap ! $321.0M |
Open | High | Low | Value | Volume |
$1.78 | $1.93 | $1.78 | $563.4K | 302.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 108 | $1.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.90 | 4926 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 108 | 1.880 |
2 | 8000 | 1.855 |
4 | 12250 | 1.850 |
2 | 32500 | 1.840 |
1 | 2500 | 1.835 |
Price($) | Vol. | No. |
---|---|---|
1.900 | 4926 | 1 |
1.920 | 2311 | 1 |
1.930 | 275 | 1 |
1.935 | 10400 | 1 |
1.940 | 5260 | 1 |
Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |